Clinical Trial Update: A Study That Compares the Extent to Which Apomorphine Becomes Available in the Body After Taking Either an Investigational Drug Containing Apomorphine or Apomorphine That is Injected Under the Skin in People With PD Complicated by "OFF" Episodes [Phase 2]

View source ↗

Summary

Phase 2 trial comparing systemic exposure of apomorphine from an investigational apomorphine-containing drug versus subcutaneous apomorphine in Parkinson diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED | Results posted: 2020-08-13